Serotonergic-catecholaminergic antagonism and locomotor control.
D000818:Animals; D002395:Catecholamines / Q000037:antagonists & inhibitors*; D004285:Dogs; D006220:Haloperidol / Q000494:pharmacology; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D008124:Locomotion / Q000187:drug effects; D009122:Muscle Hypertonia / Q000503:physiopathology / Q000662:veterinary*; D009468:Neuromuscular Diseases / Q000134:cerebrospinal fluid / Q000503:physiopathology / Q000662:veterinary*; D010643:Phenoxybenzamine / Q000494:pharmacology*; D010646:Phentolamine / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D012701:Serotonin; D012702:Serotonin Antagonists; D014364:Tryptophan / Q000134:cerebrospinal fluid
D002395:Catecholamines; D012702:Serotonin Antagonists; D010643:Phenoxybenzamine; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D014364:Tryptophan; D011433:Propranolol; D006220:Haloperidol; D010646:Phentolamine